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AbstractAU : Pleaseconfirmthatallheadinglevelsarerepresentedcorrectly
Children typically experience more mild symptoms of Coronavirus Disease 2019 (COVID19) when compared to adults. There is a strong body of evidence that children are also
less susceptible to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection with the ancestral viral isolate. However, the emergence of SARS-CoV-2 variants
of concern (VOCs) has been associated with an increased number of pediatric infections.
Whether this is the result of widespread adult vaccination or fundamental changes in the
biology of SARS-CoV-2 remain to be determined. Here, we use primary nasal epithelial
cells (NECs) from children and adults, differentiated at an air–liquid interface to show that
the ancestral SARS-CoV-2 replicates to significantly lower titers in the NECs of children
compared to those of adults. This was associated with a heightened antiviral response to
SARS-CoV-2 in the NECs of children. Importantly, the Delta variant also replicated to
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significantly lower titers in the NECs of children. This trend was markedly less pronounced
in the case of Omicron. It is also striking to note that, at least in terms of viral RNA, Omicron
replicated better in pediatric NECs compared to both Delta and the ancestral virus. Taken
together, these data show that the nasal epithelium of children supports lower infection
and replication of ancestral SARS-CoV-2, although this may be changing as the virus
evolves.
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policy and the authors of this manuscript have the
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and data presented in this manuscript are of the
authors and are independent of these relationships.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
Coronavirus Disease 2019 (COVID-19), causes a broad range of clinical symptoms, ranging
from asymptomatic infection to potentially fatal acute respiratory distress syndrome (ARDS).
Children typically experience mild symptoms of COVID-19 when compared to adults [1].
There is also a significant body of evidence with the ancestral viral strain that children are less
susceptible to SARS-CoV-2 infection and less likely to transmit the virus [2]. These findings
have been echoed in multiple single site studies where, both within and outside of households,AU : Anab
the infection rate of the ancestral SARS-CoV-2 among children <10 years old is significantly
lower than that of adults [3,4]. Reduced SARS-CoV-2 infection and transmission is also
observed in juvenile ferrets compared to their older counterparts [5].
The reasons for less frequent SARS-CoV-2 infection and symptoms in children infected
with the ancestral virus strain remain unclear and may be influenced by a multitude of factors. There is evidence to suggest that nasal epithelial cells (NECs), the first site of infection,
are fundamentally different in children compared to adults. Gene expression studies using
the nasal epithelium of healthy individuals suggest that the transcript for the SARS-CoV-2
receptor, angiotensin-converting enzyme 2 (ACE2), is expressed at lower levels in children
than in adults [6]. However, this has yet to be validated on a protein level. Moreover, this
does not appear to be the case in all patient cohorts [7,8]. Following binding of the SARSCoV-2 spike protein to ACE2, the host surface transmembrane serine protease 2 (TMPRSS2)
is also involved in viral entry into the cell [9]. NECs from children express less TMPRSS2
mRNA than those from adults, which may contribute to less frequent pediatric infections
with SARS-CoV-2 [10]. However, this has also yet to be confirmed at protein level. In addition to differential receptor expression, pediatric and adult NECs may also mount fundamentally different innate immune response to SARS-CoV-2. Recent RNA sequencing of the
whole epithelium from pediatric and adult proximal airways suggests that there is a higher
expression of genes associated with inflammation and the antiviral response in children compared to adults [11,12]. While increased inflammation and interferon production have previously been associated with elevated COVID-19 severity [13], it is important to note that such
studies refer to the inflammatory response in the lower respiratory tract, where any immunopathology may lead to respiratory distress [14]. In contrast, inflammation in the upper respiratory tract plays an important role in controlling early viral replication. Specifically, elevated
levels of type I IFN effectively inhibit the replication of SARS-CoV-2 across multiple studies
[15–17]. Consistent with these data, nasopharyngeal swabs from SARS-CoV-2-infected children display elevated levels of interferons and inflammatory markers compared to those of
SARS-CoV-2-infected adults [7].
During the course of the SARS-CoV-2 pandemic, the ancestral virus has undergone significant mutations resulting in the emergence of variants of concern (VOCs) such as Delta and

Abbreviations: ACE2, angiotensin-converting
enzyme 2; ALI, air liquid interface; ARDS, acute
respiratory distress syndrome; COVID-19,
Coronavirus Disease 2019; DEG, differentially
expressed gene; DGE, differential gene expression;
ECL, enhanced chemiluminescence; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; GO,
gene ontology; h.p.i, hours post-infection; HE,
hematoxylin–eosin; HPRT, hypoxanthine-guanine
phosphoribosyltransferase; HRP, horseradish
peroxidase; NEC, nasal epithelial cell; NP,
nucleoprotein; ORF, open reading frame; PAS,
periodic acid–Schiff; qRT-PCR, quantitative reverse
transcription PCR; ROI, region of interest; SARSCoV-2, Severe Acute Respiratory Syndrome
Coronavirus 2; TMPRSS2, transmembrane serine
protease 2; VOC, variant of concern; ZO-1, zonal
occludens-1.
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Omicron. These VOCs have multiple mutations in the spike protein, the N protein, and various open reading frames (ORFs) of the virus, which has resulted in their increased transmissibility and potentially differing clinical outcome [18]. The growing dominance of VOCs has
raised speculation that the epidemiology of SARS-CoV-2 infection has fundamentally
changed, specifically in terms of the role that children play in spreading the virus. For example,
epidemiological household transmission studies have found little evidence of differential susceptibility to Delta in children compared to adults [19,20]. In addition, data from South Africa
[21] and the United States [22] found a rapid increase in pediatric COVID-19-related hospital
admission associated with the Omicron wave. These data may suggest that VOCs have evolved
such that they are now able to evade any protection that the innate immune response has previously afforded children in terms of infection with the ancestral virus [7,12,18,23]. However,
the extrapolation of epidemiology studies to fundamental immunology are complicated by the
fact that the Delta and Omicron waves emerged at a time when a large percentage of the adult
population were eligible for vaccination while vaccination of children <12 years old often
lagged behind. Therefore, the role of pediatric innate immunity during VOC infection remains
undefined.
Here, we use primary NECs, differentiated at an air–liquid interface, to investigate differential infection kinetics and antiviral responses to SARS-CoV-2 (ancestral and VOCs) infection
in children and adults.

Results
Pediatric nasal epithelial cells are phenotypically different to adult nasal
epithelial cells
To investigate the role of NECs in SARS-CoV-2 infection, adult and pediatric NECs were differentiated at an air–liquid interface. The phenotype of these cells at baseline (i.e., prior to
infection) was then assessed. Adult NECs grew as a pseudostratified columnar epithelium
with scattered goblet cells and ciliated epithelial cells (Fig 1A). Pediatric NECs also grew as a
pseudostratified columnar epithelium with ciliated epithelial cells and goblet cells (Fig 1A).
However, scattered cells with pyknotic nucleus and condensed cytoplasm were also
observed, leaving pseudocysts in the epithelium (S1 Fig). This is potentially indicative of
higher cell turnover and metabolic rate in the pediatric epithelial cells [24,25]. Immunofluorescence images of zonal occludens-1 (ZO-1)-stained NECs showed that tight junction proteins were built up closely toward the apical region of both adult and pediatric cells (Fig 1B).
Periodic acid–Schiff (PAS) staining indicated the presence of mucus-producing cells (Fig
1A) in both pediatric and adult NECs. Consistent with these data, MUC5AC staining was
detected exclusively on the apical layer, thus demonstrating mucus secretion by differentiated NECs (Fig 1B). Previous mRNA expression studies suggest that pediatric NECs express
lower levels of ACE2 and TMPRSS2 compared to their adult counterparts [6,10]. However,
these findings are inconsistent between patient cohorts and have not been investigated at a
protein level [8]. Immunofluorescence staining suggested that pediatric NECs had a trend
toward lower surface levels of ACE2 compared to their adult counterparts (Fig 1B and 1C).
Accordingly, we sought to confirm these data using western blot on the NECs from a larger
number of donors (n = 5) (Figs 1D, 1E and S3). While the same trend was observed by western blot (increased levels of ACE2 in adult NECs), this failed to reach statistical significance
(Figs 1D, 1E and S3). There was no observable trend in TMPRSS2 levels between adult and
pediatric NECs (Figs 1D, 1E and S3).
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Fig 1AU
. Pediatric
: AbbreviationlisthavebeencompiledforthoseusedinFigs1
nasal epithelial cells are phenotypically different to4;adult
S1 nasal
S3; S1andS2Tables:Pleaseverifythatallentriesarecorrect:
epithelial cells. (A) Representative HE- and PAS-stained
sections of pediatric and adult NECs culture differentiated at an air–liquid interface (representative of 2 adults (1 female, 1 male) and 3 pediatric (1
female, 2 males) donors). Arrowheads indicate ciliated cells, arrows indicate goblet cells, and double-tailed arrows indicate mucus-producing cells
as determined by PAS staining. Images taken at 400× magnification. Each scale bar is equivalent of 150 μm. (B) Representative z-projections (150
optical sections) of pediatric and adult NECs cultures differentiated at an air–liquid interface and immunolabeled against endogenous ZO-1 and
ACE2 (cyan and yellow, respectively, top panels) and MUC5AC and ACE2 (cyan and yellow, respectively, bottom panels). Cells were also stained
with DAPI (blue) and phalloidin (magenta) to indicate the nucleus and actin filaments, respectively. The area in the dotted box in the images on
left are shown magnified in the respective rows (10-μm bar applies to all images in the row). The merged image on right shows the orthogonal view
of the z-stacks. The arrowheads indicate the ZO-1-stained profiles (top panels) and mucus secretion (MUC5AC) in the lower panels. (C)
Quantification of ACE2 immunofluorescence as described in the Materials and methods. Mean ± SEM is shown. Each data point represents the
average of 5 separate images taken from 1 donor (adult (N = 4, 2 females, 2 male) and pediatric (N = 3, 2 females, 1 male)). (D) Relative ACE2 and
TMPRSS2 protein levels compared to GAPDH in adult (3 females, 2 males) and pediatric (3 females, 2 males) NECs. Each data point represents a
different donor. Mean ± SEM is shown. (E) Representative western blot of NECs from 3 adult and 3 pediatric donors blotted for ACE2, TMPRSS2,
and GAPDH. ACE2 is indicated with an arrow. Each donor is indicated by unique symbol that is used consistently throughout all figures. Data are
contained in S1 Data, and raw western blot images are available in S1 Raw images. ACE2, angiotensin-converting enzyme 2; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; HE, hematoxylin–eosin; NEC, nasal epithelial cell; PAS, periodic acid–Schiff; TMPRSS2,
transmembrane serine protease 2; ZO-1, zonal occludens-1.
https://doi.org/10.1371/journal.pbio.3001728.g001

Pediatric nasal epithelial cells are less permissive to SARS-CoV-2 replication
We next sought to determine if pediatric NECs were less susceptible than adult NECs to
SARS-COV-2 replication with the ancestral virus (QLD/02). Strikingly, significantly reduced
SARS-CoV-2 replication was observed in pediatric NECs at 24 and 48 hours post-infection (h.
p.i) (Fig 2A). Reduced SARS-CoV-2 N protein level was also observed in pediatric NECs at 24
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Fig 2. Lower replication of SARS-CoV-2 in pediatric nasal epithelial cells. (A) PFUs of SARS-CoV-2 (QLD02) from the apical surface of NECs
(N = 8 adults: 5 females, 3 males and N = 10 children: 5 females, 5 males) obtained at 24, 48, and 72 h.p.i. Cells were infected with 1.25 × 105 PFU. (B)
Representative western blot of adult and pediatric donor blotted for SARS-CoV-2 NP at various time points post-infection. All the western blot results
for SARS-CoV-2 NP are shown as S2 Fig. (C) Relative SARS-CoV-2 NP levels compared to GAPDH in pediatric and adult NECs. � NP levels of 1
pediatric donor at 24 h.p.i are missing. (D) Expression of ORF3a RNA (log10) in infected cells at various time points relative to HPRT expression. Each
donor is indicated by unique symbol that is used consistently throughout all figures. Mean ± SEM is shown. p <0.05� , p <0.01�� . Statistical analysis
performed as described in the Materials and methods. Data are contained in S1 Data, and raw western blot images are available in S1 Raw images.
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HPRT, hypoxanthine-guanine phosphoribosyltransferase; h.p.i, hours post-infection; NEC, nasal
epithelial cell; NP, nucleoprotein; PFU, plaque-forming unit; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.
https://doi.org/10.1371/journal.pbio.3001728.g002

h.p.i and 72 h.p.i (Figs 2B, 2C and S2). RNA levels showed a similar pattern although no statistical significance was recorded (Fig 2D). After infection, there was also no significant difference in ACE2 levels between adult and pediatric donors (S3 Fig).

Pediatric nasal epithelial cells mount a strong antiviral response to
SARS-CoV-2
To gain a further insight into the observed decrease of SARS-CoV-2 replication in pediatric
NECs, RNA-seq was performed on infected adult and pediatric cells 72 h.p.i with the ancestral
SARS-CoV-2 virus. PCA analysis showed that infected cells formed distinct clusters depending
on whether they were derived from pediatric or adult donors (Fig 3A). Numerous differentially
expressed genes were recorded in infected cells (Fig 3B). In infected pediatric NECs, gene
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Fig 3. Pediatric epithelial cells have a different transcriptional response to SARS-CoV-2. (A) Principal component
analysis for the global transcriptional response of naive pediatric and adult NECs. Data points represent individual
donors (N = 5 adults: 4 females, 1 male and N = 5 pediatric donors: 2 females, 3 males). (B) Volcano plot illustrating
DEGs of infected pediatric NECs compared to adult cells. DEGs statistically different between the 2 patient groups
with a fold change of >1.5 are indicated in orange. DEGs statistically different between 2 groups with a fold change of
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<1.5 are shown in purple. DEGs not statistically different between 2 groups with a fold change of >1.5 are shown in
green. NS = not significant. (C) GO analysis of DEGs in infected pediatric NECs was displayed by the bar chart. The
bars of significantly GO-enriched (overrepresented p value < 0.05) results were marked in red, x-axis reflects the gene
count hits as a percentage over genes in each GO category; y-axis reflects different GO terms. (D) GO analysis of DEGs
in adult NECs was displayed by the bar chart. The bars of significantly enriched GO (overrepresented p value < 0.05)
enrichment results were marked in purple and represent the gene count hits (as a percentage over number of genes in
a given category); y-axis reflects different GO terms. Data are contained in S1 Data. DEG, differentially expressed gene;
GO, gene ontology; NEC, nasal epithelial cell; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.
https://doi.org/10.1371/journal.pbio.3001728.g003

ontology (GO) enrichment analysis (Fig 3C) demonstrated a strong interferon response, with
GO terms such as “viral process,” “type I interferon signaling,” “response to virus,” “regulation
of defense response to virus,” “negative regulation of viral genome replication,” “defense
response to virus,” and “cellular response to interferon alpha.” None of these GO terms were
identified among the top differentially expressed GO terms in adult cells infected with SARSCoV-2 (Fig 3D). In contrast, GO terms such as “cellular response to sterol,” “Wnt signalling
pathway,” and “response to tumor necrosis factor” were recorded. To confirm that these data
were not restricted to a DESeq2 analysis, gene expression data were also analyzed using limma
(S1 and S2 Tables). Once again, in infected pediatric NECs GO terms such as “response to
virus,” “cellular response to cytokine stimulus,” and “defense response to virus” were recorded.
In contrast, infected adult NECs were associated with GO terms such as “detection of stimulus
involved in sensory perception” and “sensory perception.” To further validate these data, we
assessed gene expression by qPCR of 3 genes associated with inflammatory/antiviral response
—interferon-induced protein with tetratricopeptide repeats 1 (IFIT1), C-X-C motif chemokine ligand 10 (CXCL10), and interferon-stimulated gene 15 (ISG15). Infected pediatric NECs
had significantly higher levels of IFIT1 compared to infected adult NECs (Fig 4A). Infected
pediatric NECs also had a trend of increased IFN-alpha, IFN-beta, and CXCL10 protein levels
following SARS-CoV-2 infection, although donor-to-donor variability precluded significance
(Fig 4B–4D).
We next sought to investigate if we observed similar phenotype in pediatric epithelial cells
infected with selected VOCs (Delta and Omicron). At 24 h.p.i, there were significantly high
titers of infectious virus and viral RNA in adult epithelial cells infected with the ancestral virus
(QLD02) and Delta compared to the epithelial cells of children (Fig 4E). Interestingly, while a
similar (albeit not significant) trend was observed in Omicron infectious virus titers, there was
no difference in Omicron RNA levels in pediatric versus adult NECs (Fig 4F).

Discussion
Large clinical data sets and systematic reviews suggest that children are less often infected with
the ancestral SARS-CoV-2 and have less severe symptoms than adults [26–28]. However, the
mechanisms driving these observations have been unclear. Here, we have provided the first
experimental evidence that the pediatric nasal epithelium may play an important role in reducing the susceptibility of children to ancestral SARS-CoV-2.
Previous studies have suggested that the reduced susceptibility of children to SARS-CoV-2
infection is due to reduced mRNA expression of SARS-CoV-2 receptors ACE2 and TMPRSS2.
Specifically, it has been proposed that the lower level of ACE2 and TMPRSS2 in pediatric
upper airways epithelial cells limits disease severity and viral infectivity in children [6,29],
although this has remained somewhat controversial [7,8]. In the present study, while there was
a trend toward decreased ACE2 protein levels in pediatric NECs, there was significant donorto-donor variability that precluded statistical significance. We interpret these data as
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Fig 4. Pediatric epithelial cells have a stronger type I IFN response to viral infection. (A) Expression of interferon
associated genes in ancestral SARS-CoV-2 (QLD02)-infected epithelial cells relative to uninfected controls (48 h.p.i). Each
data point represents a different donor (N = 8 adults: 5 females, 3 males and N = 10 pediatric: 5 females, 5 males). Gene
expression (fold change) was calculated using the ΔΔCt method relative to GAPDH expression. (B–D) Levels of IFN-alpha,
IFN-beta, and CXCL10 in epithelial cell supernatant at 24 and 48 h.p.i with ancestral SARS-CoV-2 (QLD02). Mean ± SEM

PLOS Biology | https://doi.org/10.1371/journal.pbio.3001728 August 1, 2022

8 / 19

PLOS BIOLOGY

Pediatric nasal epithelial cells & SARS-CoV-2

is shown. p <0.05� , statistical analysis performed as described in the Materials and methods. Each donor is indicated by
unique symbol that is used consistently throughout all figures. Number of donors shown in 4B and 4C (N = 8 adults: 5
females, 3 males and N = 10 children: 5 females, 5 males) and 4D (N = 5 adults: 4 females, 1 male and N = 5 children: 2
females, 3 males) were different. (E) Lower replication of SARS-CoV-2 Delta in pediatric nasal epithelial cells. PFUs of
SARS-CoV-2 from the apical surface of nasal epithelial cells NECs obtained at 24 h.p.i. Cells were infected with 1.7 × 104
PFU of each of the respective viral variants. (F) Expression of ORF3a RNA in infected cells at relative to GAPDH
expression. Each donor is indicated by unique symbol that is used consistently throughout all figures (N = 10 adults: 5
females, 5 males and N = 10 children: 5 females, 5 males). Mean ± SEM is shown. p < 0.05� , p < 0.01�� . Statistical analysis
performed as described in the Materials and methods. Data are contained in S1 Data. GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; h.p.i, hours post-infection; PFU, plaque-forming unit; SARS-CoV-2, Severe Acute Respiratory Syndrome
Coronavirus 2.
https://doi.org/10.1371/journal.pbio.3001728.g004

suggesting that ACE2 levels may contribute to, but are not the sole factor, in the increased
resistance of children to SARS-CoV-2.
Despite donor-to-donor differences in ACE2 expression, we consistently observed a significant reduction in ancestral SARS-CoV-2 (QLD02) replication in pediatric NECs compared to
NECs of adults. Given that the nasal epithelium is the first site of SARS-CoV-2 infection, these
data are consistent with the reduced number of SARS-CoV-2-infected children recorded in
household and school transmission studies [30,31]. However, we recognize it is challenging to
compare data from controlled experimental studies to data obtained from patient sampling,
where it is difficult to control for time of sampling relative to the onset of infection. Rather,
decreased viral replication in pediatric epithelial cells is consistent with experimental studies in
ferrets where aged ferrets showed higher viral load and longer nasal virus shedding [5].
Consistent with reduced ancestral SARS-CoV-2 replication in the nasal epithelium of children, pediatric epithelial cells had a more pronounced pro-inflammatory response (compared
to adult cells) following an ancestral SARS-CoV-2 infection. In particular, a pronounced interferon response and the expression of interferon stimulated genes (ISGs) were higher in
infected pediatric, compared to adult, NECs. Increased ISG expression and the subsequent
antiviral response may contribute to the reduced viral replication observed in pediatric cells.
Importantly, unlike the lower respiratory tract, any resultant cell death or immunopathology
in the upper respiratory tract is unlikely to lead to respiratory distress and therefore remains
beneficial to the host [13]. These findings are consistent with those of Maughan and colleagues,
who analyzed transcriptional profile of airway (tracheobronchial) epithelium and observed
up-regulated type I and II IFNs associated genes in children [11]. Similarly, in the nasal fluid of
children and adults presenting to the emergency department with SARS-CoV-2, there were
significantly higher levels of IFN-α2 in the fluid derived from children. Increased interferon
signaling was also recorded in the nasopharyngeal transcriptome of children compared to that
of adults during early SARS-CoV-2 infection [7].
The question remains as to why pediatric epithelial cells mount a stronger inflammatory
and antiviral response to ancestral SARS-CoV-2 compared to adult cells. This may represent
an adaptation to the increased antigenic challenge observed in childhood. Alternatively, it is
possible that increased antigenic exposure in childhood “trains” nasal epithelium in children
to mount a stronger pro-inflammatory response to any antigenic challenge. It is also possible
that metabolic differences between pediatric and NECs (as potentially suggested by the different morphologies of the cells) could alter gene expression.
It is striking to note that the VOC Delta also replicated significantly better in the NECs of
adults compared to those of children. These data suggest that any increase in pediatric infections during the Delta wave are unlikely to be due to the fact that the virus has substantially
evaded the innate immune response of pediatric NECs and are instead more likely attributable
to other factors (e.g., age-dependent differences in prior infection and/or vaccination).
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Interestingly, the Delta variant replicated to higher titers in the NECs of both adults and children when compared to the ancestral virus. This is consistent with previous studies [32] and
may be associated with the increased transmissibility of Delta compared to the ancestral virus.
Interestingly, at least in adults, the more recent Omicron variant did not replicate more efficiently in the NECs than the earlier Delta variant. These data support suggestions that Omicron does not necessarily have a replicative advantage over Delta in the URT of adults [33],
and the observed increase in transmission with Omicron in adults is more likely reflective of
increased antibody evasion [34–37].
Surprisingly, age-dependent differences in viral replication in NECs were much less pronounced in the case of Omicron. Indeed, there was no notable difference in Omicron RNA
titers at 24 h.p.i in adult versus pediatric NECs. These data may provide preliminary evidence
that the Omicron variant, at least to some extent, is able to evade aspects of the pediatric innate
immune response, as has previously been demonstrated [38]. Whether this is sufficient to
result in an increased number of pediatric infections during the Omicron wave [39,40], or
whether other factors are more important, remains to be determined. However, it is striking to
note (at least in terms of RNA levels) increased titers of Omicron in pediatric NECs compared
to infection with Delta and the ancestral virus. These data are consistent with the increased
number of pediatric infections observed during the Omicron wave [39,40].
Finally, it is important to recognize the limitations of this study. Due to the difficulties associated with obtaining NECs from children, only a limited number of donors could be used for
this study. However, as donors were not selected according to susceptibility to respiratory viral
infection, their responses should be broadly representative of healthy children. Furthermore,
our data focused on the role of nasal epithelial cells in age-dependent differences in SARSCoV-2 infection. Nevertheless, there may be other mechanisms to explain the reduced susceptibility of children to SARS-CoV-2 infection that were not measured in the present study. For
example, children and adolescents have higher titers of preexisting antibodies to SARS-CoV-2
compared to adults [41]. This study is unable to ascertain if this plays a more significant role
than the nasal epithelium in protecting children from infection in vivo.

Materials and methods
Cell collection and ethics statement
Primary NECs were collected from healthy adult (aged 19 to 66 years old) donors by placing a
sterile nasal mucosal curette (Arlington Scientific, USA) in the mid-inferior portion of the
inferior turbinate during July 2018 to May 2021 (during which time there was only sporadic
community cases of COVID-19 in Queensland and Western Australia). Informed consent was
obtained from all donors. Primary NECs were obtained from healthy pediatric donors (aged 2
to 11 years old) in the same manner while under general anesthetic prior to ear, nose, and
throat (ENT)-related surgeries including tonsillectomies, adenoidectomies, or for sleep
apnoea. Children did not have any other unknown underlying condition at the time of recruitment and sampling. This study was approved by the University of Queensland’s Human
Research Ethics Committee (2020001742), the Queensland Children’s Hospital and Health
Service Human Research Ethics Committee (HREC/16/QRCH/215, HREC/10/QRCH/78),
Queensland University of Technology Human Research Ethics Committee 17000000039), and
St John of God Subiaco Hospital Human Ethics Committee as part of the Western Australia
Epithelial Research Program (WAERP) (Ethics #901). Primary NECs were established as previously described [42–44] and stored in freezing media (FBS with 10% DMSO) at passage 1 or
2. In total, we included 38 donors in this study (N = 15 adult (7 females, 8 male, 37.9 ± 16.5
years old) and N = 23 pediatric (11 female, 12 male, 5.6 ± 2.7 years old)).
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Cell culture
African green monkey kidney epithelial Vero cells were maintained in MEM (Invitrogen),
containing 10% (v/v) heat-inactivated fetal bovine serum (Cytiva), 100 U/mL penicillin, and
streptomycin (Life Technologies Australia). Cell lines were obtained from American Type Culture Collection (ATCC; Virginia, USA). Primary NECs were expanded and passaged in Pneumacult EX Plus media (STEMCELL Technologies, Canada). After initial expansion, NECs
were seeded at a density of 4 to 5 × 105 cells/transwell on 6.5-mm transwell polyester membranes with 0.4 μm pores (Corning Costar, USA) and cultured in EX Plus media (STEMCELL
Technologies). Cells were monitored for confluence. When a confluent monolayer was
achieved, cells were “air-lifted” by removing the media from the apical chamber and replacing
the basolateral media with Pneumacult air liquid interface (ALI) media (STEMCELL Technologies) [45]. Medium was replaced in the basal compartment 3 times a week, and the cells were
maintained in ALI conditions for at least 3 weeks until ciliated cells and mucus were observed
and cells obtained a transepithelial electrical resistance (TEER) measurement greater than 800
O/cm2. Fully differentiated cultures were used in downstream infection experiments.

Viral stocks
SARS-CoV-2 isolate hCoV-19/Australia/QLD02/2020 (QLD02) (used as the original ancestral
virus), hCoV-19/Australia/QLD1893C/2021 (QLD1893C) (GISAID Accession ID; EPI_ISL_
2433928; Delta), and hCoV-19/Australia/NSW-RPAH-1933/2021 (GISAID Accession ID;
EPI_ISL_6814922; Omicron) were kindly provided by Queensland Health Forensic and Scientific Services, Queensland Department of Health, and the Kirby Institute (in collaboration
with NSW Health Pathology). In this setting, we collectively acknowledge the contribution of
the scientists and pathologists of NSW Health Pathology and the Kirby Institute to this project.
Growth and use of primary isolates was under approval of the NSW Chef Health Officer following independent scientific review. Virus was amplified in Vero cells expressing human
TMPRSS2 and titrated by plaque assay [46]. All studies with SARS-CoV-2 were performed
under physical containment 3 (PC3) conditions and were approved by the University of
Queensland Biosafety Committee (IBC/374B/SCMB/2020).

Viral infection
Differentiated adult and pediatric NECs were infected with mock (PBS), QLD02 (1.25 × 105
PFU or 1.7 × 104 PFU), QLD1517 (1.7 × 104 PFU), or NSW1933 (1.7 × 104 PFU). Specifically,
100 μL of virus or PBS was placed on the epithelial surface in the apical compartment and
incubated for 1 hour at 37 ˚C. Following incubation, excess virus was removed from the transwell, and cells were incubated at 37 ˚C with 5% CO2. Every 24 hours, the basolateral media was
refreshed with 1 mL of new ALI media. At predetermined time points, post-infection 100 μL
of PBS was added to the apical compartment, and cells were incubated at 37 ˚C with 5% CO2
for 10 minutes. The apical supernatant was subsequently collected and stored at −80 ˚C. Cells
were lysed with Buffer RLT (Qiagen, USA) containing 0.01% β-mercaptoethanol for RNA
analysis. Alternatively, cells were lysed in 2% SDS/PBS lysis buffer (2% SDS/PBS buffer, 10%
10× PhosSTOP, 4% 25× protease inhibitor) for protein analysis or fixed overnight in 4% paraformaldehyde for histology.

Histology
Fixed cells on a transwell membrane were routine processed and embedded in paraffin, sectioned at 5 μm, and subsequently stained with hematoxylin–eosin (HE) or periodic acid–Schiff
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(PAS). Sections were assessed for cellular morphology by a veterinary pathologist (H.B.O.)
blinded to the experimental design.

Immunofluorescence
Differentiated epithelial cells grown on a transwell membrane were fixed with 4% paraformaldehyde (Cat#15710, Electron Microscopy Sciences) in PBS for 45 minutes at room
temperature, followed by a blocking with 0.5% BSA (Sigma) in PBS for 30 minutes and permeabilization with 0.02% of Triton X-100 (Sigma) in PBS for 15 minutes at room temperature. After washing twice with PBS/BSA and a second blocking step for 10 minutes at room
temperature, samples were incubated with primary antibodies overnight at 4 ˚C. Primary
antibodies were diluted in 0.5% BSA in PBS blocking solution: 1:400 ZO-1 (Cat#40–2200,
Thermo Fisher Scientific), 1:1,000 MUC5AC (Cat#MA5-12178, Thermo Fisher Scientific),
and 1:500 ACE2 (Cat#AF933, R&D Systems). After 3 washing steps with 0.5% BSA/PBS for
5 minutes each time, the samples were incubated in secondary antibody: 1:1,000 Alexa Flour
555 donkey anti-goat (Cat#A21432, Invitrogen) for 2.5 hours at room temperature in dark,
and after 3 washes in PBS and 3 washes with 0.5% BSA/PBS, the cells were incubated with a
1:1,000 Alexa Fluor 488 goat anti-mouse (Cat#A32728, Invitrogen) for 2.5 hours at room temperature covered from light. The cells were simultaneously stained with 1:400 Alexa Fluor 647
Phalloidin (Cat#A22287 Invitrogen) and 1:1,000 DAPI. After 3 washes in PBS, the transwell
membranes with cells were cut with a scalpel, briefly dipped in milli-q water, and mounted on
a class slide using ProLong Gold Antifade Mountant (Cat# P10144, Thermo Fisher Scientific).
Mounted samples were imaged on a spinning disk confocal system (Marianas; 3I) consisting
of an Axio Observer Z1 (Carl Zeiss) equipped with a CSU-W1 spinning disk head (Yokogawa
Corporation of America), ORCA-Flash4.0 v2 sCMOS camera (Hamamatsu Photonics), and
63× 1.4 NA/Plan-Apochromat/180 μm WD objective. Image acquisition was performed using
SlideBook 6.0 (3I). A total of 150 optical sections from 5 random regions of interest (ROIs)
from each sample were acquired from the top of the differentiated epithelial cells. Image processing was performed using Fiji/ImageJ (Version 2.1.0/1.53c) as follows: Background was
reduced using the Substract Backgound 50 pixel rolling ball radius, and the mean fluorescence
intensity (MFI, a.u. arbitrary units) was measured from the average intensity images.

Western blotting
For total cell lysates, cells were washed twice with cold PBS and lysed with SDS/PBS lysis buffer
(2% SDS/PBS buffer, 10% 10× PhosSTOP, 4% 25× protease inhibitor). Pierce BCA protein
assay kit (Thermo Fisher Scientific) was used to equalize protein amounts. After adding LDS
buffer (4×) with reducing agent (10×), mix protein samples were subsequently boiled at 100 ˚C
for 10 minutes to denature proteins. Proteins were separated on 4% to 15% mini protean TGX
precast gels (Biorad) in running buffer (200 mM Glycine, 25 mM Tris, 0.1% SDS (pH 8.6)),
transferred to nitrocellulose membrane (Cat#1620112, BioRad) in blot buffer (48 nM Tris, 39
nM Glycine, 0.04% SDS, 20% MeOH), and subsequently blocked with 5% (w/v) BSA in Trisbuffered saline with Tween 20 (TBST) for 30 minutes. The immunoblots were analyzed using
primary antibodies incubated overnight at 4 ˚C and secondary antibodies linked to horseradish peroxidase (HRP) (Invitrogen), and after each step, immunoblots were washed 3× with
TBST. HRP signals were visualized by enhanced chemiluminescence (ECL) (BioRad) and
imaged with an AI600 Chemiluminescent Imager (Cytiva). Primary antibodies include rabbit
GAPDH (14C10) monoclonal antibody (1:2,500 dilution, Cat#2118, Cell Signaling Technology), rabbit anti-SARS-CoV-2 nucleoprotein/NP antibody (1:1,000 dilution, Cat#40143-R040,
Sino Biological), goat polyclonal ACE2 (1:500 dilution, Cat#AF933, R&D Systems), and rabbit
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anti-TMPRSS2 antibody (1:1,000 dilution, Cat#ab109131, Abcam). ImageJ (version 1.53) was
used to quantify the protein expression level relative to GAPDH levels.

Cytokine levels
Cytokine levels were measured by AlphaLISA (Perkin Elmer) according to the manufacturer’s
instructions.

Quantification of infectious virus
SARS-CoV-2 titers in cell culture supernatants were determined by plaque assay on Vero cells,
as described previously [46].

RNA extraction and quantitative reverse transcription PCR (qRT-PCR)
RNA was extracted from NECs using Nucleozole reagent according to the manufacturer’s
instructions, DNA was removed by DNase I (Thermo Fisher Scientific) treatment, and 1-μg
DNA-free RNA was reverse transcribed into cDNA using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) on a Mastercycler Thermocycler (Eppendorf, Hamburg, Germany) according to the manufacturer’s instructions using random primers. Realtime PCR was performed on generated cDNA with SYBER Green (Invitrogen) using QuantStudio 6 Flex Real-Time PCR System, an Applied Biosystems Real-Time PCR Instruments
(Thermo Fisher Scientific). Gene expression was normalized relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or hypoxanthine-guanine phosphoribosyltransferase (HPRT)
expression; fold change was calculated using the ΔΔCt method. All primers used in this study
are listed in Table 1.

RNA sequencing
RNA-Seq libraries were prepared using the Illumina stranded total RNA prep ligation with the
Ribo-Zero plus kit (Illumina) and IDT for Illumina RNA UD Indexes according to the standard manufacturer’s protocol. Briefly, 50 ng of total RNA was depleted of rRNA and then fragmented by heat. cDNA was synthesized from the fragmented RNA using random primers.
The first strand cDNA was converted into dsDNA in the presence of dUTP to maintain the
“strandedness” of the library. The 30 ends of the cDNA were adenylated, and pre-index
anchors were ligated. The libraries were then amplified with 14 to 16 cycles of PCR incorporating unique indexes for each sample to produce libraries ready for sequencing. The libraries
Table 1. Primers used in the present study.
Primer name
hIFIT1
hCXCL10

Sequence (50 -30 )
FW:TTGCCTGGATGTATTACCAC
RV: GCTTCTTGCAAATGTTCTCC
FW: GTGGCATTCAAGGAGTACCTC
RV: GCCTTCGATTCTGGATTCAGACA

hISG15

FW: GAGAGGCAGCGAACTCATCT;
RV: CTTCAGCTCTGACACCGACA)

hGAPDH

FW: CGAGATCCCTCCAAAATCAA;
RV: TTCACACCCATGACGAACAT

hHPRT

FW: TCAGGCAGTATAATCCAAAGATGGT
RV: AGTCTGGCTTATATCCAACACTTCG

ORF3a

FW: ACAAGCCTCACTCCCTTTCG
RV: TGAACACCCTTGGAGAGTGC

https://doi.org/10.1371/journal.pbio.3001728.t001
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were quantified on the Perkin Elmer LabChip GX Touch with the DNA High Sensitivity
Reagent kit (Perkin Elmer). Libraries were pooled in equimolar ratios, and the pool was quantified by qPCR using the KAPA Library Quantification Kit—Illumina/Universal (KAPA Biosystems) in combination with the Life Technologies Viia 7 real-time PCR instrument.
Sequencing was performed using the Illumina NextSeq500 (NextSeq control software
v2.2.0/Real Time Analysis v2.4.11). The library pool was diluted and denatured according to
the standard NextSeq protocol and sequenced to generate single-end 76 bp reads using a 75
cycle NextSeq500/550 High Output reagent Kit v2.5 (Illumina). After sequencing, fastq files
were generated using bcl2fastq2 (v2.20.0.422), which included trimming the first cycle of the
insert read. Library preparation and sequencing was performed at the Institute for Molecular
Bioscience Sequencing Facility (University of Queensland).

RNA sequencing analysis
The quality of the trimmed RNA-seq reads was assessed with FastQC [47] and MultiQC [48].
Salmon [49] was used for transcript quantification from human transcriptome (GENCODE
Release 36, accessed in December 2020). A decoy aware transcriptome file was created for
Salmon transcript quantification followed by the transcriptome index [49]. The R package,
DESeq2 [50], was then used for differential gene expression (DGE) analysis and further validated through using the limma R package [51] with Voom transformation [52]. DGEs between
virus and mock infected samples were analyzed by controlling the effect of the age group and
gender of the individual samples, genes with adjusted p-value less than 0.05 were considered
significant. Gene set enrichment analysis was performed using the R package GOseq [53]. All
the R scripts were run on R-Studio platform (RStudio Team 2020, v 1.4.1717).

Statistical analysis
Where sufficient cell numbers were present, samples were performed in duplicate, and the
results were averaged and shown as a single data point. If sufficient cells were not present, a
single transwell was used to determine the response of that donor to viral infection. Outliers of
continual variables were removed using ROUT’s test (Q = 1%). Data were tested for normality
using the Shapiro–Wilk test. Where data were normally distributed, data were analyzed using
an unpaired 2-tailed Student t test. Where data were not normally distributed, data were analyzed using a Mann–Whitney U test. Significance was set at p < 0.05. Each donor is shown
with a distinct symbol that is used consistently throughout the paper.

Conclusions
The data presented here strongly suggest that the nasal epithelium of children is distinct and
that it may afford children some level of protection from ancestral SARS-CoV-2, although
such age-dependent differences become less pronounced in the case of Omicron infection.

Supporting information
S1 Fig. Pediatric nasal epithelial cells display pseudocysts. Representative HE-stained section of pediatric NECs culture differentiated at an air–liquid interface. Scale bar is equivalent
of 150 μm. HE, hematoxylin–eosin; NEC, nasal epithelial cell.
(TIF)
S2 Fig. Relative SARS-CoV-2 NP levels compared to GAPDH in pediatric and adult NECs.
Western blot of adults and pediatric donors blotted for SARS-CoV-2 N at various time points
post-infection; N = 5 adults (3 females, 2 males) and N = 8 children (4 females, 4 males). � NP
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levels of Pediatric donor 4 at 24 h.p.i are missing. Data are contained in S1 Data and raw western blot images are available in S1 Raw image. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; h.p.i, hours post-infection; NEC, nasal epithelial cell; NP, nucleoprotein; SARS-CoV-2,
Severe Acute Respiratory Syndrome Coronavirus 2.
(TIF)
S3 Fig. Relative ACE2 levels compared to GAPDH in pediatric and adult NECs. Western
blot of adults and pediatric donors blotted for ACE at 24 h.p.i; N = 3 adults (1 females, 2
males) and N = 5 children (3 females, 2 males). Data are contained in S1 Data and raw western
blot images are available in S1 Raw images. ACE2, angiotensin-converting enzyme 2; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; h.p.i, hours post-infection; NEC, nasal epithelial
cell; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.
(TIF)
S1 Table. DEGs of infected pediatric NECs (72 h.p.i) compared to adult cells with statistics. DEGs were identified using DESeq2, genes with adjusted p-value less than 0.05 value were
considered significant. DEG, differentially expressed gene; h.p.i, hours post-infection; NEC,
nasal epithelial cell.
(DOCX)
S2 Table. DEGs of infected pediatric NECs (72 h.p.i) compared to adult cells with statistics. DEGs were identified using limma, genes with adjusted p-value less than 0.05 value were
considered significant. DEG, differentially expressed gene; h.p.i, hours post-infection; NEC,
nasal epithelial cell.
(DOCX)
S1 Data. Raw data for figures used in the manuscript.
(PDF)
S1 Raw images. The original, uncropped images supporting the western blot in Figs 1E,
2B, S2 and S3.
(RAR)
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Loske J, Röhmel J, Lukassen S, Stricker S, Magalhães VG, Liebig J, et al. Pre-activated antiviral innate
immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat Biotechnol. 2022;
40(3):319–324. https://doi.org/10.1038/s41587-021-01037-9 PMID: 34408314.

13.

Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020; 584(7821):463–469. https://doi.org/10.1038/
s41586-020-2588-y PMID: 32717743.

14.

Short KR, Kroeze EJBV, Fouchier RAM, Kuiken T. Pathogenesis of influenza-induced acute respiratory
distress syndrome. Lancet Infect Dis. 2014; 14(1):57–69. https://doi.org/10.1016/S1473-3099(13)
70286-X PMID: 24239327.

15.

Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat
Immunol. 2022; 23(2):165–176. https://doi.org/10.1038/s41590-021-01091-0 PMID: 35105981.

16.

Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, et al. Inhibition of SARSCoV-2 by type I and type III interferons. J Biol Chem. 2020; 295(41):13958–13964. https://doi.org/10.
1074/jbc.AC120.013788 PMID: 32587093.

17.

Rajah MM, Hubert M, Bishop E, Saunders N, Robinot R, Grzelak L, et al. SARS-CoV-2 Alpha, Beta,
and Delta variants display enhanced Spike-mediated syncytia formation. EMBO J. 2021; 40(24):
e108944. https://doi.org/10.15252/embj.2021108944 PMID: 34601723.

18.

Khateeb J, Li Y, Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention
approaches. Crit Care. 2021;12; 25(1):244. https://doi.org/10.1186/s13054-021-03662-x PMID:
34253247.

19.

Chen F, Tian Y, Zhang L, Shi Y. The role of children in household transmission of COVID-19: a systematic review and meta-analysis. Int J Infect Dis. 2022; 122:266–275. https://doi.org/10.1016/j.ijid.2022.
05.016 PMID: 35562045.

20.

Ogata T, Tanaka H, Nozawa Y, et al. Increased Secondary Attack Rate among Unvaccinated Household Contacts of Coronavirus Disease 2019 Patients with Delta Variant in Japan. Int J Environ Res Public Health. 2022; 19(7):3889. https://doi.org/10.3390/ijerph19073889 PMID: 35409572.

21.

Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, et al. Paediatric hospitalisations
due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health. 2022. https://doi.org/10.1016/S2352-4642
(22)00027-X PMID: 35189083.

22.

Marks KJ, Whitaker M, Anglin O, Milucky J, Patel K, Pham H, et al. Hospitalizations of Children and
Adolescents with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, July 2021-January 2022.
MMWR Morb Mortal Wkly Rep. 2022; 71(7):271–278. https://doi.org/10.15585/mmwr.mm7107e4
PMID: 35176003.

23.

Yi H, Wang J, Wang J, Lu Y, Zhang Y, Peng R, et al. The Emergence and Spread of Novel SARS-CoV2 Variants. Front Public Health. 2021; 9:696664. https://doi.org/10.3389/fpubh.2021.696664 PMID:
34409009.

24.

Bardanzellu F, Fanos V. How could metabolomics change pediatric health? Ital J Pediatr. 2020; 46
(1):37. https://doi.org/10.1186/s13052-020-0807-7 PMID: 32216818.

25.
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